3E Bioventures Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 6
Professionals
  • Investments
  • 56
  • Portfolio
  • 34
  • Exits
  • 13
Exits

3E Bioventures Capital General Information

Description

3E Bioventures Capital is a healthcare focused venture capital firm based in Beijing, China. The firm seeks to make investments in the drug, device, diagnostics, healthcare information technology and medical services sectors.

Contact Information

Website
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Suite 701, Tower C, Tsinghua Science Park
  • Number 1 Zhongguancun East Road
  • Beijing, Haidian 100084
  • China
+86 010 0000 0000

3E Bioventures Capital Investments (56)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Cardea Bio 12-Jan-2021 Later Stage VC 0000 Other Healthcare Technology Systems Generating Revenue
000000 000000 07-Jan-2021 00000 00000 000.00 Other Healthcare Technology Systems Generating Revenue
000000 0000000 19-Nov-2020 00000 00000 000.00 Other Healthcare Technology Systems Generating Revenue 000 000
00000 000000000 18-Nov-2020 00000 00000 00000 Drug Discovery Clinical Trials - General 00000 000 00.0
0000000000 15-Sep-2020 00000 00000 00000 Biotechnology Generating Revenue
0000000000 09-Sep-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3 00000 000 00.0
000 00000000000 26-Aug-2020 00000 00000 000.00 Biotechnology Profitable
00 000000000000 29-May-2020 00000 00000 00000 Drug Discovery Generating Revenue/Not Profitable
Purinomia Biotech 07-May-2020 Early Stage VC 00.000 Biotechnology Generating Revenue
Chigene 14-Apr-2020 Later Stage VC Decision/Risk Analysis Generating Revenue
You’re viewing 10 of 56 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

3E Bioventures Capital Exits (13)

Company Name Exit Date Exit Type Exit Size
OncoImmune 23-Nov-2020 Merger/Acquisition 00000
00 000000000000 02-Oct-2020 000 00000
000000 000000000 24-Sep-2020 000000000000000000
000000000 29-Jul-2020 000 00000
00000 0000000000 31-Oct-2018 000 0000
0000000 00000000'0 22-Sep-2018 000000000000000000 000.00
00000000 000000000 06-Jul-2016 000000000000000000
000000000 06-Jan-2016 000
BGI Tech 14-Jan-2015 Merger of Equals
Chiral Quest Secondary Transaction - Open Market
You’re viewing 10 of 13 exits. Get the full list »

3E Bioventures Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

3E Bioventures Capital Team (9)

Name Title Deals Funds Boards Office
Lue Sun President 0 Beijing, China
Karen Liu Ph.D Founding Partner 00 0 0 Beijing, China
Joy Yang Ph.D Venture Partner Beijing, China
Francine Fang Ph.D Partner 0 Beijing, China
Hao Zhou Partner Beijing, China
You’re viewing 5 of 9 team members. Get the full list »

3E Bioventures Capital Co-Investors (124)

Name With Exits Lead Partner Series Industry
ShangBay Capital 3 0 Series chart Industry bar
Tsingyuan Ventures 0 0 Series chart Industry bar
Bay City Capital 0 0 Series chart Industry bar
Cowin Capital 0 Series chart Industry bar
Northern Light Venture Capital 0 0 Series chart Industry bar
You’re viewing 5 of 124 co-investors. Get the full list »